Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205913
Company: AMNEAL PHARMS

Products on ANDA 205913

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PRASUGREL	PRASUGREL HYDROCHLORIDE	EQ 5MG BASE	TABLET;ORAL	Prescription	BX	No	No
PRASUGREL	PRASUGREL HYDROCHLORIDE	EQ 10MG BASE	TABLET;ORAL	Prescription	BX	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205913

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/19/2018	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
02/04/2022	SUPPL-8	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.
11/04/2019	SUPPL-1	Labeling-Medication Guide, Labeling-Package Insert, Labeling-Container/Carton Labels		Label is not available on this site.

Therapeutic Equivalents for ANDA 205913

PRASUGREL

There are no Therapeutic Equivalents.